Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2016, Article ID 3272483, 21 pages
http://dx.doi.org/10.1155/2016/3272483
Review Article

Treatment of Dermatological Conditions Associated with HIV/AIDS: The Scarcity of Guidance on a Global Scale

1Harvard Medical School, Boston, MA, USA
2HIV Department, World Health Organization, Geneva, Switzerland
3Department of Dermatology, University of California San Francisco School of Medicine, San Francisco, CA, USA
4Department of Maternal, Child and Adolescent Health, World Health Organization, Geneva, Switzerland
5Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Bartlett Hall 6R, 55 Fruit Street, Boston, MA 02114, USA

Received 24 September 2015; Accepted 2 March 2016

Academic Editor: Andrea Mangano

Copyright © 2016 Suchismita Paul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNAIDS, The gap report, 2014, http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf.
  2. R. J. Hay, N. E. Johns, H. C. Williams et al., “The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions,” Journal of Investigative Dermatology, vol. 134, no. 6, pp. 1527–1534, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Tschachler, P. R. Bergstresser, and G. Stingl, “HIV-related skin diseases,” The Lancet, vol. 348, no. 9028, pp. 659–663, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. E. N. Nnoruka, J. C. Chukwuka, and B. Anisuiba, “Correlation of mucocutaneous manifestations of HIV/AIDS infection with CD4 counts and disease progression,” International Journal of Dermatology, vol. 46, supplement 2, pp. 14–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Mendiratta, S. Mittal, A. Jain, and R. Chander, “Mucocutaneous manifestations in children with human immunodeficiency virus infection,” Indian Journal of Dermatology, Venereology and Leprology, vol. 76, no. 5, pp. 458–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Coopman, R. A. Johnson, R. Platt, and R. S. Stern, “Cutaneous disease and drug reactions in HIV infection,” The New England Journal of Medicine, vol. 328, no. 23, pp. 1670–1674, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Hu, K. McKoy, A. Papier et al., “Dermatology and HIV/AIDS in Africa,” Journal of Global Infectious Diseases, vol. 3, no. 3, pp. 275–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Schmid-Ott, B. Jaeger, H. W. Kuensebeck, R. Ott, and F. Lamprecht, “Dimensions of stigmatization in patients with psoriasis in a ‘Questionnaire on Experience with Skin Complaints’,” Dermatology, vol. 193, no. 4, pp. 304–310, 1996. View at Publisher · View at Google Scholar · View at Scopus
  9. T. A. Maurer, “Dermatologic manifestations of HIV infection,” Topics in HIV Medicine, vol. 13, no. 5, pp. 149–154, 2005. View at Google Scholar · View at Scopus
  10. M. E. Garman and S. K. Tyring, “The cutaneous manifestations of HIV infection,” Dermatologic Clinics, vol. 20, no. 2, pp. 193–208, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Lowe, R. A. Ferrand, R. Morris-Jones et al., “Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection,” Pediatric Infectious Disease Journal, vol. 29, no. 4, pp. 346–351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Hay, S. E. Bendeck, S. Chen et al., “Skin diseases,” in Disease Control Priorities in Developing Countries, D. T. Jamison, J. G. Breman, A. R. Measham et al., Eds., chapter 37, The International Bank for Reconstruction and Development/The World Bank Group, Washington, DC, USA, 2006. View at Google Scholar
  13. M. Waugh, “Skin diseases—clinical indicator of immune status in HIV infection,” International Journal of Dermatology, vol. 44, no. 8, pp. 705–706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. A. M. Cook, I. G. Finlay, A. G. K. Edwards et al., “Efficiency of searching the grey literature in palliative care,” Journal of Pain and Symptom Management, vol. 22, no. 3, pp. 797–801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  15. UNAIDS, HIV Estimates with Uncertainty Bounds. UNAIDS Report on the Global AIDS Epidemic—2013, 2014, http://www.unaids.org/en/dataanalysis/knowyourepidemic/epidemiologypublications/.
  16. WHO, Database of National HIV and TB Guidelines, 2005–2011, 2014, http://www.who.int/hiv/pub/national_guidelines/en/.
  17. USAID, AIDSTAR-One, National Treatment Guidelines, June 2014, https://aidsfree.usaid.gov/resources/guidance-data/treatment.
  18. The Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers and Children, June 2014, http://www.emtct-iatt.org/.
  19. AIDSspace, “Library,” 2014, http://www.aidsspace.org/library.php.
  20. Cochrane Review Group on HIV/AIDS, June 2014, http://hiv.cochrane.org/about-cochrane-hivaids-group.
  21. G. H. Guyatt, A. D. Oxman, G. E. Vist et al., “GRADE: an emerging consensus on rating quality of evidence and strength of recommendations,” The British Medical Journal, vol. 336, no. 7650, pp. 924–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. The World Bank Group 2014, July 2014, http://data.worldbank.org/country.
  23. M. J. Rico, S. A. Myers, and M. R. Sanchez, “Guidelines of care for dermatologic conditions in patients infected with HIV. Guidelines/Outcomes Committee. American Academy of Dermatology,” Journal of the American Academy of Dermatology, vol. 37, no. 3, part 1, pp. 450–472, 1997. View at Google Scholar
  24. S. G. Pahwa, E. L. Handelsman, and H. T. Shin, Dermatologic Manifestations. HIV Clinical Resource, August 2014, http://www.hivguidelines.org/wp-content/uploads/p-derm-7.14.08.pdf.
  25. A. D. Oxman, J. N. Lavis, and A. Fretheim, “Use of evidence in WHO recommendations,” The Lancet, vol. 369, no. 9576, pp. 1883–1889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. P. G. Shekelle, E. Ortiz, S. Rhodes et al., “Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated?” Journal of the American Medical Association, vol. 286, no. 12, pp. 1461–1467, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. World Health Organization, Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults, World Health Organization, 2014, http://www.who.int/maternal_child_adolescent/documents/skin-mucosal-and-hiv/en/.